Header image

Session 5A: From Australia to the world: practical pathways to global expansion

Tracks
Track 1
Thursday, May 21, 2026
12:50 PM - 1:35 PM

Details

For Australian life sciences companies looking to expand globally, success depends on choosing the right markets, partners and pathways at the right time. This session explores how companies can work with Austrade as a mechanism to support international growth, leveraging market insight, global networks and on-the-ground support to de-risk expansion across key international markets. The session will also spotlight the newly created Perth–New England–Galway Bio Bridge as an example of a structured, market-to-market approach to global engagement, alongside a real company case study illustrating how Australian innovation has successfully leveraged these pathways to establish offshore presence and accelerate global growth.


Speaker

Agenda Item Image
Dr. Jennifer Hoffmann
Executive Director
New England Medical Innovation Center

Panellist

Agenda Item Image
Ms Sangeetha Krishnamoorthy
Senior Director
Austrade India

Panellist

Tamlyn O'Connor
Head of Global Trade & Partnerships
AusBiotech

Panellist

Agenda Item Image
Dr. Nicholas Pachuda
Partner
Neovate Capital

Chair

Agenda Item Image
Mr Peter Traianou
President and CEO
Emerging Health Connections, Llc

Panellist

loading